Endometrial cancer: Current concepts and management

Surgical Oncology Clinics of North America

Volumn 7, Issue 2, 1998, Pages 271-284

  Ball, H G ^a   Elkadry, E A ^a  

^a University of Massachusetts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; ESTROGEN; MEDROXYPROGESTERONE; PACLITAXEL; TAMOXIFEN;

ABDOMINAL HYSTERECTOMY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; LYMPHADENECTOMY; PHASE 3 CLINICAL TRIAL; PROGNOSIS; RECURRENT CANCER; REVIEW; SALPINGOOOPHORECTOMY;

EID: 0031958922     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30270-9     Document Type: Review

References (38)

1. Aalders J. Abeier V. Kolstad P. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients Obstet Gynecol 56 1980 419 427
2. Ackerman I. Malone S. Thomas G. Endometrial carcinoma—Relative effectiveness of adjuvant irradiation vs therapy reserved for relapse Gynecol Oncol 60 1996 177 183
3. Ball H.G. Do we know the best therapy for early endometrial cancer? Gynecol Oncol 60 1996 173 175
4. Ball H.G. Blessing J.A. Lentz S.S. A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: A Gynecologic Oncology Group study Gynecol Oncol 62 1996 278 281
5. Barnhill D. O’Connor D. Farley J. Clinical surveillance of gynecologic cancer patients Gynecol Oncol 46 1992 275 280
6. Berchuck A. Anspach C. Evans A.C. Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma Gynecol Oncol 59 1995 20 24
7. Bokhman J.V. Two pathogenetic types of endometrial carcinoma Gynecol Oncol 15 1983 10 17
8. Childers J.M. Brzechffa P.R. Hatch K.D. Laparoscopically assisted surgical staging (LASS) of endometrial cancer Gynecol Oncol 51 1993 33 38
9. Corn B.W. Lanciano R.M. Greven K.M. Endometrial cancer with para-aortic adenopathy: Patterns of failure and opportunities for cure Int J Radiat Oncol Biol Phys 24 1992 223 227
10. Fanning J. Nanavati P.J. Hilgers R.D. Surgical staging and high dose rate brachytherapy for endometrial cancer: Limiting external radiotherapy to node-positive tumors Obstet Gynecol 87 1996 1041 1044
11. Fisher B. Costantino J.P. Redmond C.K. Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 J Natl Cancer Inst 86 1994 527 537
12. Gibson L.E. Barakat R.R. Venkatraman E.S. Endometrial pathology at dilatation and curettage of breast cancer patients: Comparison of tamoxifen users and nonusers Cancer J Sci Am 2 1996 34 38
13. Grady D. Gebretasdik T. Kerlikowske K. Hormone replacement therapy and endometrial cancer risk: A meta-analysis Obstet Gynecol 85 1995 304 313
14. Granai C.O. Arena B. Gajewski W.H. Uterine Malignancy Morris P.J. Mait R.A. Oxford Textbook of Surgery 1994 Oxford University Press New York 1438 1443
15. Gronroos M. Salmi T.A. Vuento M.H. Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension Cancer 71 1993 1279 1282
16. Hawwa A.M. Nahhas W.A. Coperhaver E.H. Postmenopausal bleeding Lahey Clinic Foundation Bulletin 19 1970 61 70
17. Johnstone P.A.S. Rohde D.C. Swartz S.E. Port site recurrences after laparoscopic and thoracoscopic procedures in malignancy J Clin Oncol 14 1996 1950 1956
18. Kelley R.M. Baker W.H. Progestational agents in the treatment of carcinoma of the endometrium N Engl J Med 264 1961 216 222
19. Kurman R.J. Zaino R.J. Norris H.J. Endometrial carcinoma Kurman R.J. Blaustein’s Pathology of the Female Genital Tract 1994 Springer-Verlag New York 439 486
20. Lentz S.S. Advanced and recurrent endometrial carcinoma: Hormonal therapy Semin Oncol 21 1994 100 106
21. Martin-Hirsch P.L. Lilford R.J. Jarvis G.J. Adjuvant progestagen therapy for the treatment of endometrial cancer: Review and meta-analyses of published randomized controlled trials Eur J Obstet Gynecol Reprod Biol 65 1996 207 210
22. Morrow C.P. Bundy B.N. Kurman R.J. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study Gynecol Oncol 40 1991 55 65
23. Muss H.B. Chemotherapy of metastatic endometrial cancer Semin Oncol 21 1994 107 113
24. Orr J.W. Holimon J.L. Orr P.F. Stage I corpus cancer: Is teletherapy necessary? Am J Obstet Gynecol 176 1997 777 789
25. Orr J.W. Jr. Holloway R.W. Orr P.F. Surgical staging of uterine cancer: An analysis of perioperative morbidity Gynecol Oncol 42 1991 209 216
26. Pacheco J.C. Kempers R.D. Etiology of postmenopausal bleeding Obstet Gynecol 32 1968 40 46
27. Parker S.L. Tong T. Bolden S. Cancer statistics, 1997 CA Cancer J Clin 47 1997 5 27
28. Patsner B. Mann W.J. Cohen H. Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma Am J Obstet Gynecol 158 1988 399 402
29. Pearl M.L. Valea F.A. Fischer M. A randomized controlled trial of postoperative nasogastric tube decompression in gynecologic oncology patients undergoing intraabdominal surgery Obstet Gynecol 88 1996 399 402
30. Pettersson F. Annual report of the results of treatment in gynecological cancer 1995 International Federation of Gynecology and Obstetrics Stockholm
31. Pritchard K.I. Screening for endometrial cancer: Is it effective? Ann Intern Med 110 1989 177 179
32. Reddoch J.M. Burke T.W. Morris M. Surveillance for recurrent endometrial carcinoma: Development of a follow-up scheme Gynecol Oncol 59 1995 221 225
33. Ries L.A.G. Kosary C.L. Hankey H.F. SEER cancer statistics review, 1973-1974 1997 National Cancer Institute Bethesda, MD NIH Publication
34. Shumsky A.G. Brasher P.M.A. Stuart G.C.E. Risk-specific follow-up for endometrial carcinoma patients Gynecol Oncol 65 1997 379 382
35. Shumsky A.G. Stuart G.C. Brasher P.M. An evaluation of routine follow-up of patients treated for endometrial carcinoma Gynecol Oncol 55 1994 229 233
36. Thigpen T. Vance R.B. Khansur T. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix Semin Oncol 22 1995 67 75
37. Zaino R.J. Kurman R. Herbold D. The significance of squamous differentiation in endometrial carcinoma. Data from a Gynecologic Oncology Group study Cancer. 68 1991 2293 2302
38. Zaino R.J. Kurman R.J. Diana K.L. Pathologic models to predict outcome for women with endometrial adenocarcinoma: The importance of the distinction between surgical stage and clinical stage. A Gynecologic Oncology Group study Cancer. 77 1996 1115 1121